Term ends Nov 24, 2028 · Medium confidence
20-year base term ends Nov 24, 2028
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 8,744,550), so the cap could be lower.
Held by Invivo Corporation
Filed Jun 2, 2014 as application 14/293,411 · Granted Sep 26, 2017
Base term plus 387 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2008
2028
Clock starts
Nov 24, 2008
Nov 24, 2008
Term ends
Nov 24, 2028
Nov 24, 2028
Granted
Sep 26, 2017
Sep 26, 2017
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
387
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,290,569, US 8,744,550.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 387 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 2 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 24, 2008, when application 12/277,061, the earliest non-provisional in its chain, was filed (this one was filed Jun 2, 2014) | Nov 24, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +387 days, USPTO patent term adjustment record | Dec 16, 2029 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,290,569, US 8,744,550) | capped to Nov 24, 2028 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 24, 2028 | Medium confidence |
This family
| US 8,290,569 | In force Feb 2031 | Feb 2031 |
| US 8,744,550 | In force no later than Nov 2028 | no later than Nov 2028 |
| US 9,770,209 | this patent Nov 2028 | Nov 2028 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 5, 2014 Reel 33471, frame 102 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Goldman Sachs Bank USA | Security Interest |
| Sep 29, 2014 Reel 33845, frame 837 | Goldman Sachs Bank USA | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products , Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Hologic, Inc. | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Biolucent, LLC | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Cytyc Corporation | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Cytyc Surgical Products , Limited Partnership | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Direct Radiography Corp. | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Suros Surgical Systems, Inc. | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Third Wave Technologies, Inc. | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Gen-Probe Incorporated | Release of Security Interest |
| Oct 13, 2014 Reel 33973, frame 842 | Sentinelle Medical Inc.; Hologic, Inc. | Invivo Corporation | Assignment of Assignor's Interest |
| Jul 17, 2015 Reel 36126, frame 683 | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Security Interest Release Reel Frame 033471 0102 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc. | Security Interest Release Reel Frame 033471 0102 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Biolucent, LLC | Security Interest Release Reel Frame 033471 0102 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Corporation | Security Interest Release Reel Frame 033471 0102 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Surgical Products, Limited Partnership | Security Interest Release Reel Frame 033471 0102 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Direct Radiography Corp. | Security Interest Release Reel Frame 033471 0102 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Suros Surgical Systems, Inc. | Security Interest Release Reel Frame 033471 0102 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Third Wave Technologies, Inc. | Security Interest Release Reel Frame 033471 0102 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Gen-Probe Incorporated | Security Interest Release Reel Frame 033471 0102 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Nov 2028
Term ends Nov 24, 2028. No further fees fall due before then
Note
The 387 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,290,569, US 8,744,550.
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.